Read Now

With 12+ new products ready to be launched by Novartis in the next 3-5 years, the strategic importance of an effective market entry cannot be overstated. Discover some effective strategies that can enable product launch success with AI & Analytics from Industry experts from Astra Zeneca, Ipsen and Otsuka

Enable Product Launch Success

with AI & Analytics

Key reasons for missing

launch forecasts

 Navigating regulatory roadblocks

and competitive dynamics

Leveraging AI to drive

launch success

Discusses the importance of preparing for multiple label scenarios and pre-clearing promotional materials, highlighting the collaborative relationship with regulatory agencies to expedite innovation for patient benefit.

Navigating regulatory roadblocks and competitive dynamics

 Key reasons for missing launch forecasts

Discusses the five main reasons for launch failures:

  • Payer activation and reimbursement challenges 
  • Regulatory roadblocks and competitive dynamics 
  • Inadequate market adoption by healthcare professionals 
  • Field force effectiveness and efficiency challenges 
  • Patient engagement and adoption issues 

Leveraging AI to drive launch success

Discusses the risks and challenges inherent in implementing generative AI solutions. While the potential for transforming drug launches is real, tying AI to specific pain points to solve is essential.  Whether it’s for training sales teams or developing content, the opportunities to drive business faster are real.

Maximize launch success by blending creativity with technology

On-Demand Webinar | Duration: 60 minutes

Maximize launch success and revenue peaks for Novartis' upcoming stars like Iptacaopan and Pelacarsen with our webinar on leveraging creative intelligence for a blockbuster market entry